Scientifica / 2012 / Article

Research Article | Open Access

Volume 2012 |Article ID 649090 |

D. M. Walsh, S. H. Shah, M. A. Simpson, N. V. Morgan, S. Khaliq, R. C. Trembath, S. Q. Mehdi, E. R. Maher, "A Novel ABCA12 Mutation in Two Families with Congenital Ichthyosis", Scientifica, vol. 2012, Article ID 649090, 6 pages, 2012.

A Novel ABCA12 Mutation in Two Families with Congenital Ichthyosis

Academic Editor: G. Lesinski
Received24 Oct 2012
Accepted19 Nov 2012
Published31 Dec 2012


Autosomal recessive congenital ichthyosis (ARCI) is a rare genetically heterogeneous disorder characterized by hyperkeratosis in addition to dry, scaly skin. There are six genes currently known to be associated with the disease. Exome sequencing data for two affected individuals with ichthyosis from two apparently unrelated consanguineous Pakistani families was analysed. Potential candidate mutations were analysed in additional family members to determine if the putative mutation segregated with disease status. A novel mutation (c.G4676T, p.Gly1559Val) in ABCA12 occurred at a highly conserved residue, segregated with disease status in both families, and was not detected in 143 control chromosomes. Genotyping with microsatellite markers demonstrated a partial common haplotype in the two families, and a common founder mutation could not be excluded. Comparison to previously reported cases was consistent with the hypothesis that severe loss of function ABCA12 mutations are associated with Harlequin Ichthyosis and missense mutations are preferentially associated with milder phenotypes. In addition to identifying a possible founder mutation, this paper illustrates how advances in genome sequencing technologies could be utilised to rapidly elucidate the molecular basis of inherited skin diseases which can be caused by mutations in multiple disease genes.

1. Introduction

Autosomal recessive congenital ichthyosis (ARCI) is a rare and genetically heterogeneous disorder characterized by hyperkeratosis in addition to dry, scaly skin [1]. It is a rare condition, with an estimated prevalence of approximately 1 in 200,000 births [2]. ARCI consists of three major subtypes, among which the range of clinical features and severity of disease vary [3]. The subtypes include Harlequin ichthyosis (HI), which is the most severe and devastating form of ichthyoses and is fatal in the majority of affected neonates [4, 5]. Lamellar ichthyosis (LI) and congenital ichthyosiform erythroderma (CIE) make up the further two subtypes and are not as severe as HI. The HI patients present with critical and significant clinical features at birth, including severe ectropion, eclabium, and flattened ears, in addition to large plate-like scales over the entire body [4, 6]. The patients who suffer from CIE on the other hand exhibit fine scales in addition to variable erythroderma, while LI patients show less severe erythroderma, but have thick, dark scales over the entire body [6, 7]. To date, multiple genes have been shown to be associated with ichthyosis, including ALOXE3, ALOX12B, TGM1, CYP4F22, NIPAL4, and ABCA12 [3, 6]. Mutations in the ABCA12 gene have been identified in all three subtypes of ARCI. The resulting defect in the ABCA12 protein is thought to play a causative role in the development of the disease by affecting lipid transport, which consequently causes abnormal development of the skin barrier [3, 8]. Here we report a novel missense mutation in exon 32 of ABCA12 (p.Gly1559Val) that is associated with the development of congenital ichthyosis in two apparently unrelated families of Pakistani origin.

2. Materials and Methods

2.1. Patient Information

Two consanguineous Asian families from the remote area of the Sindh province of Pakistan were ascertained, clinically assessed, and provided blood samples for DNA analysis. For both families, DNA was available for most of the affected individuals, at least one of their parents, and some unaffected individuals (total 8 affected and 17 unaffected family members (see Figures 1(g)-1(h)). The range of clinical symptoms varied among the affected individuals; however all presented with dry, scaly skin and hyperkeratosis to the elbows, knees, feet, and hands.

2.2. Exome Sequencing

Exome sequencing was undertaken in two individuals (ICH107 and ICH204) according to the protocols used in the paper by Ostergaard et al. 2011 [9].

2.3. Microsatellite Markers

Microsatellite markers flanking ABCA12 were used to establish linkage within the two families. The following microsatellite markers were chosen: D2S2944, D2S2382, D2S164, and D2S434. PCR reactions were carried out and analysed.

2.4. Mutation Analysis of Candidate Genes

Primers were designed to flank either side of the coding exon harbouring the ABCA12 mutation using ExonPrimer [10] and were then used to determine whether the mutation segregated in additional family members by conventional Sanger sequencing.

3. Results

3.1. Clinical Features

Both families were known to be consanguineous from first cousin marriages (Figures 1(g)-1(h)). The affected individuals from family 1 presented with fine white scales over the entire body, in addition to dry skin and hyperkeratosis of the hands, feet, elbows, and knees (Figures 1(a)–1(c)). The hair of the patients seemed very dry, brittle, and thin. Deep pits were present in the toenails, and they seemed to be dystrophic. The individuals could not sweat and therefore were heat intolerant. The affected individuals in family 2 similarly showed fine white scales over the entire body in addition to rough, dry skin (Figures 1(d)–1(f)). All patients had generalized pruritis and exhibited erythematous and eczematous lesions and hypohidrosis and severe heat intolerance.

3.2. Analysis of Exome Sequencing Data

Whole exome sequencing data was obtained for the proband of each family. Filtering of the exome variant data was performed to identify homozygous previously unreported nonsynonymous changes. This reduced the number of candidate variants from the original 29,403 to 51 variants in family 1 and from 29,526 to 51 variants in family 2.

There are 6 genes currently known to be associated with ichthyosis: ALOXE3, ALOX12B, TGM1, CYP4F22, NIPAL4, and ABCA12, and although thought to be unrelated, both the probands from family 1 and family 2 harboured an identical novel missense variant, c.G4676T, p.Gly1559Val in ABCA12, (see Figure 2).

The exomic sequence flanking the putative ABCA12 mutation was amplified and sequenced from the additional 23 affected and unaffected family members. All affected individuals were homozygous for the c.G4676T mutation, all parents were heterozygous carriers, and unaffected siblings were either heterozygous carriers of the variant or homozygous wild-type (Figure 2). The mutation was not found in any of the 143 ethnically matched control chromosomes analysed.

3.3. Genotype Analysis

In order to investigate whether the c.G4676T mutation was likely to represent a founder mutation from a common ancestor or was likely to have arisen independently, 4 affected individuals from the two families were genotyped at four polymorphic microsatellite loci flanking ABCA12 (D2S2944, D2S2382, D2S164, and D2S434). Identical genotypes were present in both families at D2S2944, the closest marker to ABCA12, but different alleles were detected at D2S2382 (which maps distal to D2S2944) (Table 1). This may be due to a recombination event which may have occurred between ABCA12 and D2S2382, and, therefore, whilst the c.G4676T mutation might have occurred independently in the two families, a distant common ancestor cannot be excluded.

MarkerPhysical Location (Mb)ICH103ICH203ICH204ICH209

ABCA12 21.5

4. Discussion

Despite the genetic heterogeneity of autosomal recessive congenital ichthyosis [3, 6], exome resequencing and prioritisation of homozygous novel variants (in view of the consanguinity present in both families) enabled us to rapidly identify a candidate ABCA12 novel missense mutation. We then confirmed likely pathogenicity by segregation analysis in families and excluding the variant in ethnically matched controls. The ABCA12 gene encodes the ATP-binding cassette subfamily A member 12 protein that belongs to a family of proteins implicated in the regulation of the transport of various molecules across cell membranes [1113]. It is a keratinocyte transmembrane lipid transporter protein which has been shown to be expressed in various cells and tissues, including skin cells, placenta, lung, stomach, and liver [13, 14]. ABCA12 appears to be essential for the normal development of the epidermis, and mutations in the gene may cause defective lipid transport which consequentially leads to abnormalities in the formation of the epidermal lipid barrier [11]. Although mutations in ABCA12 are known to be associated with Ichthyosis, and many different mutations within this gene have been documented (Figure 3), the missense mutation detected in the two families we investigated had not previously been described. The segregation of the mutation within two large families, absence of the mutation in South Asian controls, and the observation that the substitution occurs at a residue that is evolutionarily conserved in all mammals, chicken, and zebrafish are all consistent with a pathogenic mutation. The p.Gly1559Val substitution maps an intracellular loop that contains the motif of the ATP-binding cassette (see Figure 4).

Our findings of a novel ABCA12 missense mutation further contribute to the mutational diversity of ABCA12-related ichthyosis and will facilitate structure-function and genotype-phenotype correlations. The finding of a CIE phenotype associated with a p.Gly1559Val missense substitution is consistent with previously reported genotype-phenotype studies (see Supplementary Table available online at and Table 2) [15]. Thus in patients with an HI phenotype, truncating mutations and deletions predominate whereas missense mutations are more common in less severe cases (CIE and LI) [16]. All patients with HI harbour at least one deletion or a truncation mutation [15]. Thus it is suggested that the p.Gly1559Val substitution, located in the first ATP-binding cassette, produces a partial loss of ABCA12 function.

Number of patientsPhenotypeMutations

42HI4.8% frameshift insertions
7.1% exonic deletions
9.5% in-frame deletions
9.5% missense
11.9% splice site
16.7% frameshift deletions
40.5% nonsense

11CIE72.7% missense
27.3% nonsense

5LI100% missense

HI: Harlequin ichthyosis.
CIE: congenital ichthyosiform erythroderma.
LI: lamellar ichthyosis.

This paper illustrates how advances in second generation sequencing can greatly facilitate the molecular diagnosis of inherited skin diseases for which a single phenotype can be caused by multiple genes. Though the current standard molecular diagnostic approach is to sequentially sequence the individual genes, second generation sequencing enables all the potentially relevant genes to be captured and sequenced simultaneously–either by disease-specific panels of genes or by exome/partial exome strategies which could provide a standard approach to be utilised for many different rare diseases.

Conflict of Interests

The authors state that there is no conflict of interests.


D. M. Walsh is supported by a Medical Research Council PhD Studentship.

Supplementary Materials

Table listing associated phenotypes of known ichthyosis ABCA12 mutations [15].

  1. Supplementary Material


  1. J. Fischer, “Autosomal recessive congenital ichthyosis,” The Journal of Investigative Dermatology, vol. 129, no. 6, pp. 1319–1321, 2009. View at: Publisher Site | Google Scholar
  2. A. Krebsová, W. Küster, G. G. Lestringant et al., “Identification, by homozygosity mapping, of a novel locus for autosomal recessive congenital ichthyosis on chromosome 17p, and evidence for further genetic heterogeneity,” American Journal of Human Genetics, vol. 69, no. 1, pp. 216–222, 2001. View at: Publisher Site | Google Scholar
  3. L. Rodríguez-Pazos, M. Ginarte, L. Fachal, J. Toribio, A. Carracedo, and A. Vega, “Analysis of TGM1, ALOX12B, ALOXE3, NIPAL4 and CYP4F22 in autosomal recessive congenital ichthyosis from Galicia (NW Spain): evidence of founder effects,” The British Journal of Dermatology, vol. 165, no. 4, pp. 906–911, 2011. View at: Publisher Site | Google Scholar
  4. A. Hovnanian, “Harlequin ichthyosis unmasked: a defect of lipid transport,” Journal of Clinical Investigation, vol. 115, no. 7, pp. 1708–1710, 2005. View at: Publisher Site | Google Scholar
  5. A. C. Thomas, T. Cullup, E. E. Norgett et al., “ABCA12 is the major harlequin ichthyosis gene,” Journal of Investigative Dermatology, vol. 126, no. 11, pp. 2408–2413, 2006. View at: Publisher Site | Google Scholar
  6. M. Akiyama, “ABCA12 mutations and autosomal recessive congenital ichthyosis: a review of genotype/phenotype correlations and of pathogenetic concepts,” Human mutation, vol. 31, no. 10, pp. 1090–1096, 2010. View at: Google Scholar
  7. M. Akiyama, “The pathogenesis of severe congenital ichthyosis of the neonate,” Journal of Dermatological Science, vol. 21, no. 2, pp. 96–104, 1999. View at: Publisher Site | Google Scholar
  8. M. Akiyama, “Pathomechanisms of harlequin ichthyosis and ABCA transporters in human diseases,” Archives of Dermatology, vol. 142, no. 7, pp. 914–918, 2006. View at: Publisher Site | Google Scholar
  9. P. Ostergaard, M. A. Simpson, F. C. Connell et al., “Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome),” Nature Genetics, vol. 43, no. 10, pp. 929–931, 2011. View at: Publisher Site | Google Scholar
  10. T. Strom, “ExonPrimer,” Institute of Human Genetics, View at: Google Scholar
  11. M. Akiyama, Y. Sugiyama-Nakagiri, K. Sakai et al., “Mutations in lipid transporter ABCA12 in harlequin ichthyosis and functional recovery by corrective gene transfer,” Journal of Clinical Investigation, vol. 115, no. 7, pp. 1777–1784, 2005. View at: Publisher Site | Google Scholar
  12. C. Lefévre, S. Audebert, F. Jobard et al., “Mutations in the transporter ABCA12 are associated with lamellar ichthyosis type 2,” Human Molecular Genetics, vol. 12, no. 18, pp. 2369–2378, 2003. View at: Publisher Site | Google Scholar
  13. T. Annilo, S. Shulenin, Z. Q. Chen et al., “Identification and characterization of a novel ABCA subfamily member, ABCA12, located in the lamellar ichthyosis region on 2q34,” Cytogenetic and Genome Research, vol. 98, no. 2-3, pp. 169–176, 2002. View at: Publisher Site | Google Scholar
  14. M. Akiyama, K. Sakai, Y. Sugiyama-Nakagiri et al., “Compound heterozygous mutations including a de novo missense mutation in ABCA12 led to a case of harlequin ichthyosis with moderate clinical severity,” Journal of Investigative Dermatology, vol. 126, no. 7, pp. 1518–1523, 2006. View at: Publisher Site | Google Scholar
  15. M. Akiyama and K. Sakai, “Mutation Database Mutations of the ATP-binding Cassette Transporter A 12 (ABCA12) associated with harlequin ichthyosis, congenital ichthyosiform erythroderma and lamellar ichthyosis,”, 2012. View at: Google Scholar
  16. D. P. Kelsell, E. E. Norgett, H. Unsworth et al., “Mutations in ABCA12 underlie the severe congenital skin disease harlequin ichthyosis,” American Journal of Human Genetics, vol. 76, no. 5, pp. 794–803, 2005. View at: Publisher Site | Google Scholar

Copyright © 2012 D. M. Walsh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles